PHK
IDXX icon

Point72 Hong Kong’s Idexx Laboratories IDXX Stock Holding History

Point72 Hong Kong’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,700
Closed -$880K – 826
2022
Q3 		$880K Buy
2,700
+700
+35% +$257K 0.03% 578
2022
Q2 		$701K Buy
2,000
+200
+11% +$81.6K 0.03% 618
2022
Q1 		$985K Sell
1,800
-500
-22% -$263K 0.03% 517
2021
Q4 		$1.51M Buy
2,300
+500
+28% +$314K 0.05% 432
2021
Q3 		$1.12M Sell
1,800
-2,400
-57% -$1.61M 0.04% 701
2021
Q2 		$2.65M Sell
4,200
-2,400
-36% -$1.33M 0.09% 316
2021
Q1 		$3.23M Buy
6,600
+5,900
+843% +$2.96M 0.11% 242
2020
Q4 		$350K Buy
+700
New +$313K 0.02% 802

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Hong Kong's IDXX Position: Q2 2024 in Review

Point72 Hong Kong sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 18,007 shares — an estimated $9.72M sold.

Point72 Hong Kong first reported a position in IDXX in Q3 2014 and held it in 18 quarters. The position peaked at $11.3M in Q4 2023. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • Point72 Hong Kong reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 18,007 Idexx Laboratories shares in Q2 2024, an estimated $9.72M.
  • Point72 Hong Kong first reported a position in Idexx Laboratories in Q3 2014 and held it in 18 quarters.
  • Point72 Hong Kong's Idexx Laboratories position peaked at $11.3M in Q4 2023.
  • 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Point72 Hong Kong's 13F filing for Q2 2024, filed 14 Aug 2024.